Abstract
Background
The surveillance guidelines following treatment completion for patients with high-grade sarcomas of the extremities are based largely upon expert opinions and consensus. In the current meta-analysis, we aim to study the utility of surveillance imaging to diagnose local and metastatic pulmonary relapses among patients with extremity soft tissue sarcomas and primary bone sarcomas.
Patients and Methods
A meta-analysis was performed to assess the sensitivity, specificity and diagnostic odds ratio (DOR) of surveillance imaging to diagnose local and metastatic pulmonary relapse among patients with sarcoma of the extremities. In addition, impact of surveillance imaging on overall survival was assessed. Heterogeneity among eligible studies was evaluated by I2 statistics. Sensitivity analysis was assessed using influence plots and Baujat plots.
Results
Ten studies including 2160 patients with sarcoma were found eligible. For diagnoses of local recurrence based on surveillance imaging (nine studies, 1917 patients), the estimated sensitivity, specificity, and DOR were 13.6%, 99.5%, and 78.15, respectively. Only 16.7% of local recurrences were diagnosed based on imaging. For diagnoses of metastatic pulmonary recurrence (eight studies; 1868 patients), estimated sensitivity, specificity, and DOR were 76.1%, 99.3%, and 1059.9, respectively. A sensitivity analysis showed significant heterogeneity among included studies. None of the included studies showed an overall-survival benefit with the use of surveillance imaging.
Conclusion
The current meta-analysis challenges the notion of routine use of imaging to detect local relapse, while favoring chest imaging, using either chest radiography or computed tomography scan, for surveillance. Further studies are required to study the ideal surveillance strategy including timing and imaging modality.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353(7):701–11.
Gamboa AC, Gronchi A, Cardona K. Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine. CA Cancer J Clin. 2020;70(3):200–29.
Potter DA, Glenn J, Kinsella T, Glatstein E, Lack EE, Restrepo C, et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol. 1985;3(3):353–66.
Ferrari A, Alaggio R. Soft tissue sarcomas. CA Cancer J Clin. 2004;54:94–109.
Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv51-67.
Greenberg DD, Crawford B. Surveillance strategies for sarcoma: Results of a survey of members of the musculoskeletal tumor society. Sarcoma. 2016; Available from: https://doi.org/10.1155/2016/8289509
Gerrand CH, Billingham LJ, Woll PJ, Grimer RJ. Follow up after primary treatment of soft tissue sarcoma: a survey of current practice in the United Kingdom. Sarcoma. 2007;2007.
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129–35.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
Egger M, Smith G, Schneider M, Bmj CM. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Baujat B, Mahé C, Pignon JP, Hill C. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med. 2002;21(18):2641–52.
Viechtbauer W, Cheung MW-L. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112–25.
Whooley BP, Gibbs JF, Mooney MM, McGrath BE, Kraybill WG. Primary extremity sarcoma: What is the appropriate follow-up? Ann Surg Oncol. 2000;7(1):9–14.
Cool P, Grimer R, Rees R. Surveillance in patients with sarcoma of the extremities. Eur J Surg Oncol. 2005;31(9):1020–4.
Labarre D, Aziza R, Filleron T, Delannes M, Delaunay F, Marques B, et al. Detection of local recurrences of limb soft tissue sarcomas: is magnetic resonance imaging (MRI) relevant? Eur J Radiol. 2009;72(1):50–3.
Cho HS, Park IH, Jeong WJ, Han I, Kim HS. Prognostic value of computed tomography for monitoring pulmonary metastases in soft tissue sarcoma patients after surgical management: A retrospective cohort study. Ann Surg Oncol. 2011;18(12):3392–8.
Chou YS, Liu CY, Chen WM, Chen TH, Chen PCH, Wu HTH, et al. Follow-up after primary treatment of soft tissue sarcoma of extremities: Impact of frequency of follow-up imaging on disease-specific survival. J Surg Oncol. 2012;106(2):155–61.
Cheney MD, Giraud C, Goldberg SI, Rosenthal DI, Hornicek FJ, Choy E, et al. MRI surveillance following treatment of extremity soft tissue sarcoma. J Surg Oncol. 2014;109(6):593–6.
Rothermundt C, Whelan JS, Dileo P, Strauss SJ, Coleman J, Briggs TW, et al. What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer. 2014;110(10):2420–6.
Puri A, Gulia A, Hawaldar R, Ranganathan P, Badwe RA. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial. Clin Orthop Relat Res. 2014;472(5):1568–75.
Rothermundt C, Seddon BM, Dileo P, Strauss SJ, Coleman J, Briggs TW, et al. Follow-up practices for high-grade extremity osteosarcoma. BMC Cancer. 2016;16(1):1–6.
Cool P, Cribb G. The impact and efficacy of surveillance in patients with sarcoma of the extremities. Bone Jt Res. 2017;6(4):224–30.
Bisogno G, Anderson J. National Comprehensive Cancer Network. Soft Tissue Sarcoma (Version 2.2022). J Natl Compr Canc Netw. Accessed December 18, 2022. [Internet]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021;32(11):1348–65.
Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, et al. Lung surveillance strategy for high-grade soft tissue sarcomas: chest x-ray or CT scan? J Am Coll Surg. 2019;229(5):449.
Thompson CA, Charlson ME, Schenkein E, Wells MT, Furman RR, Elstrom R, et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol. 2010;21(11):2262–6.
Cash T, Bettermann EL, Mitchell S, McCracken C, Qayed M, Wolfe D, et al. Routine Surveillance imaging is associated with improved postrelapse survival in patients with ewing sarcoma. J Adolesc Young Adult Oncol. 2020;9(3):394–401.
Zhou GQ, Wu CF, Deng B, Gao TS, Lv JW, Lin L, et al. An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach. Nat Commun. 2020;11(1):1–9.
Miller BJ, CarmodySoni EE, Reith JD, Gibbs CP, Scarborough MT. CT scans for pulmonary surveillance may be overused in lower-grade sarcoma. Iowa Orthop J. 2012;32:28–34.
Goel A, Christy MEL, Virgo KS, Kraybill WG, Johnson FE. Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol. 2004;25(2):429–35.
Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg. 2012;255(2):343–7.
Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, et al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016;17(5):671–80.
Liu S, Sun W, Yang S, Duan L, Huang C, Xu J, et al. Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study. Eur Radiol. 2022;32(2):793–805.
Sun BJ, Li A, Alobuia W, et al. Detection of circulating tumor DNA predicts recurrence in soft tissue sarcomas. 2023 Society of Surgical Oncology International Conference on Surgical Cancer Care. Abstract 78. JCO Precis Oncol. March 22, 2023. In.
Acknowledgement
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Srinivasan, S., Keerthivasagam, S., Kumar, S. et al. Impact of Surveillance Imaging in Detecting Local and Metastatic Lung Recurrences Among Patients with Sarcomas of the Extremities: A Systematic Review and Meta-analysis. Ann Surg Oncol 31, 213–227 (2024). https://doi.org/10.1245/s10434-023-14429-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14429-9